| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.36B | 25.78B | 18.57B | 15.94B | 13.57B | 12.33B |
| Gross Profit | 8.34B | 7.82B | 6.05B | 5.03B | 4.35B | 3.70B |
| EBITDA | 4.07B | 3.61B | 3.34B | 2.57B | 2.05B | 1.47B |
| Net Income | 2.05B | 1.67B | 1.48B | 1.09B | 976.00M | 633.14M |
Balance Sheet | ||||||
| Total Assets | 26.33B | 24.67B | 19.55B | 16.44B | 14.19B | 11.76B |
| Cash, Cash Equivalents and Short-Term Investments | 12.38B | 12.33B | 8.78B | 6.98B | 6.74B | 4.82B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 17.27B | 15.88B | 12.41B | 9.78B | 8.79B | 7.31B |
| Stockholders Equity | 7.90B | 7.74B | 6.38B | 6.20B | 5.13B | 4.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.11B | 2.81B | 817.00M | 2.01B | 1.87B |
| Operating Cash Flow | 0.00 | 5.48B | 2.99B | 1.46B | 2.57B | 1.98B |
| Investing Cash Flow | 0.00 | -1.05B | -604.00M | -1.07B | -459.82M | -1.66B |
| Financing Cash Flow | 0.00 | -881.00M | -586.00M | -149.00M | -191.60M | -403.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥28.86B | 12.43 | ― | 0.38% | 18.02% | 46.43% | |
69 Neutral | ¥51.29B | 19.22 | ― | 0.90% | 30.25% | 67.87% | |
64 Neutral | ¥5.59B | 24.73 | ― | ― | 8.77% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥10.85B | 10.90 | ― | ― | 33.34% | -25.08% | |
57 Neutral | ¥10.83B | 40.80 | ― | 1.09% | -5.70% | -215.73% |